| Target Price | $294.78 |
| Price | $279.84 |
| Potential |
5.34%
register free of charge
|
| Number of Estimates | 27 |
|
27 Analysts have issued a price target Humana 2027 .
The average Humana target price is $294.78.
This is
5.34%
register free of charge
$371.00
32.57%
register free of charge
$217.15
22.40%
register free of charge
|
|
| A rating was issued by 32 analysts: 11 Analysts recommend Humana to buy, 20 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Humana stock has an average upside potential 2027 of
5.34%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 117.76 | 130.49 |
| 10.70% | 10.81% | |
| EBITDA Margin | 3.30% | 3.20% |
| 35.61% | 2.93% | |
| Net Margin | 1.02% | 1.59% |
| 56.20% | 55.13% |
28 Analysts have issued a sales forecast Humana 2025 . The average Humana sales estimate is
This results in the following potential growth metrics:
22 Analysts have issued an Humana EBITDA forecast 2025. The average Humana EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
30 Humana Analysts have issued a net profit forecast 2025. The average Humana net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 9.99 | 17.23 |
| 50.05% | 72.47% | |
| P/E | 16.24 | |
| EV/Sales | 0.31 |
30 Analysts have issued a Humana forecast for earnings per share. The average Humana EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barclays |
Locked
➜
Locked
|
Locked | Jan 05 2026 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Dec 18 2025 |
| Jefferies |
Locked
➜
Locked
|
Locked | Dec 05 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Nov 25 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Nov 10 2025 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Oct 10 2025 |
| Mizuho |
Locked
➜
Locked
|
Locked | Oct 09 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Barclays:
Locked
➜
Locked
|
Jan 05 2026 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Dec 18 2025 |
|
Locked
Jefferies:
Locked
➜
Locked
|
Dec 05 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Nov 25 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Nov 10 2025 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Oct 10 2025 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Oct 09 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


